Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Leukemia & Lymphoma|September 14, 2004
Guillain-Barré syndrome complicating mobilization therapy in a case of B-cell chronic lymphocytic leukemiaGiovanni D'Arena, Maria Luigia Vigliotti, Vincenzo Pizza, et al.Tumori|October 7, 2005
Role of parenteral nutrition in cancer patients undergoing high-dose chemotherapy followed by autologous peripheral blood progenitor cell transplantationAlfredo Tartarone, Jenna Wunder, Gianpiero Romano, et al.Tumori|June 14, 2005
Cisplatin and weekly docetaxel as first-line therapy in patients with advanced non-small cell lung cancer a phase II studyAlfredo Tartarone, Gianpiero Romano, Giovanni Iodice, et al.International Journal of Antimicrobial Agents|April 15, 2004
Linezolid-induced bradycardia: a case reportAlfredo Tartarone, Giuseppina Gallucci, Giovanni Iodice, et al.Translational Cancer Research|February 4, 2022
Intracystic papillary breast carcinoma with DCIS in a man: a case reportEmanuela Esposito, Maurizio Di Bonito, Giovanni Iodice, et al.Journal of Cellular Physiology|January 21, 2020
Virtual reality and music therapy as distraction interventions to alleviate anxiety and improve mood states in breast cancer patients during chemotherapyAndrea Chirico, Patrizia Maiorano, Paola Indovina, et al.International Journal of Radiation Oncology, Biology, Physics|May 18, 2010
Oxaliplatin plus dual inhibition of thymidilate synthase during preoperative pelvic radiotherapy for locally advanced rectal carcinoma: long-term outcomeAntonio Avallone, Paolo Delrio, Biagio Pecori, et al.International Journal of Molecular Sciences|September 9, 2020
Progression-Free Survival and Overall Survival of CDK 4/6 Inhibitors Plus Endocrine Therapy in Metastatic Breast Cancer: A Systematic Review and Meta-AnalysisMichela Piezzo, Paolo Chiodini, Maria Riemma, et al.ESMO Open|August 2, 2017
Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)Michele Orditura, Adriano Gravina, Ferdinando Riccardi, et al.Breast (Edinburgh, Scotland)|July 26, 2024
Psychometric properties of patient-reported outcomes Common Terminology Criteria for adverse events (PRO-CTCAE®) in breast cancer patients: The prospective observational multicenter VIP studyCaterina Caminiti, Giuseppe Maglietta, Laura Arenare, et al.Pageof 2